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adjusting for a variety of covariates including the presence 
of COPD, confirmed a persisting higher likelihood of occu-
pational exposure categorised by JEM being associated 
with poorer HRQoL scores (β estimate: −0.069; p < 0.05).
Conclusions Our findings suggest that work may have 
an important link to HRQoL and that this effect can persist 
even among those who have retired. In those with COPD, 
HRQoL is worse than among those without this condition, 
but the work-associated decrement appears to be similar 
across both groups.
Keywords COPD · Health-related quality of life · Work · 
Job exposure matrix
Introduction
Chronic obstructive pulmonary disease (COPD) is a 
common respiratory condition associated with substan-
tial morbidity, including impaired health-related qual-
ity of life (HRQoL), (Almagro and Castro 2013; Mahler 
2000; Jones and Agusti 2006). While the most important 
causative agent for COPD remains tobacco smoke, other 
aetiological factors are increasingly being recognised 
and quantified. The harmful effects of inhaled occupa-
tional exposures have been consistently identified to be 
associated, on average, with 15 % of the burden of this 
disease (American Thoracic Society Statement 2003; 
Darby et al. 2012; Blanc and Torén 2007). Despite the 
prominent role of occupational factors in the aetiol-
ogy of COPD, the relationship between such exposures 
and HRQoL as a COPD outcome has not been well 
elucidated.
We wished to study the relationship between occupa-
tional exposures and HRQoL in those with and without 
Abstract 
Purpose Chronic obstructive pulmonary disease (COPD) 
is associated with substantial morbidity, including impaired 
health-related quality of life (HRQoL). Despite the promi-
nent role of occupational factors in the aetiology of COPD, 
the relationship between these exposures and HRQoL has 
not been well elucidated.
Methods A subpopulation from an epidemiological study, 
designed to assess the workplace contribution to COPD, 
was administered the EQ5D HRQoL tool. Demograph-
ics, an index of economic deprivation, health endpoints 
including the presence of COPD and lung function were 
also recorded. Workplace exposures were categorised using 
both self-reported exposures and also by the use of an 
established job exposure matrix (JEM).
Results A total of 623 individuals participated (mean age 
67.1 years). One hundred and forty-eight (24 %) reported 
having received a physician diagnosis of COPD, 355 
(57 %) were male, and 386 (62 %) were ever smokers. As 
anticipated, the presence of COPD was associated with a 
poorer HRQoL. Additionally, however, HRQoL was signif-
icantly lower in the presence of both self-reported vapours, 
gases, dusts and fumes exposure and JEM-based exposure 
irrespective of the presence of COPD. Regression analysis, 
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self-reported COPD, using the EuroQol 5 dimension 3 
level tool (The EuroQol Group 2013) (EQ-5D-3L™; sub-
sequently referred to as EQ5D). This generic HRQoL 
instrument has been used in the study of COPD and per-
forms well in comparison with other generic and disease-
specific measures. The EQ5D has a key advantage in being 
a brief battery of questions and related visual analogue 
scale (VAS) that can yield health utility scores to inform 
economic assessments of the impact of disease (Brooks 
et al. 2003; Menn et al. 2010).
We hypothesised that occupational exposures to vapours, 
gases, dusts and fume (VGDF), stratified either by self-
report or assessed through a job exposure matrix (JEM), 
would be linked to poorer HRQoL in COPD, because such 
exposures would be likely to increase the likelihood of 
work disability in the presence of such disease. We further 
wished to test whether the relationship between these expo-
sures and poorer HRQoL was limited to those with COPD 
alone or also might be manifested among those without 
such lung disease.
To address these questions, data were analysed from 
a population-based study of respiratory disease in a his-
torically industrialised part of the UK. Because this study 
originally had been designed to assess the contribution 
of workplace exposures to COPD prevalence, it collected 
information on both HRQoL and exposure to VGDF among 
persons with and without COPD (the former over a range 
of disease severity), thus allowing us to test the hypothesis 
of interest.
Materials and methods
This study was carried out as part of a larger epidemiologi-
cal study of a randomly selected population of Sheffield 
(UK) residents over the age of 55 years. The details of this 
larger study are published elsewhere in detail (Darby et al. 
2012). In brief, the study used a rolling system to recruit 
a selected population of Sheffield North residents. The 
sampling frame was drawn randomly from patient records 
held in a primary, or community, care database. A second 
sampling frame, designed to supplement COPD case prev-
alence in the study population, was drawn from a tertiary 
care respiratory physiology department.
All participants were asked to self-complete a struc-
tured questionnaire including items eliciting demographic 
information, self-reported respiratory symptoms, self-
reported physician-made diagnoses of various respiratory 
conditions (including asthma, COPD, emphysema and 
chronic bronchitis), smoking history (yielding a pack-
years cumulative exposure), longest held occupation and 
self-reported previous or current workplace exposures to 
VGDF. The inclusion of the latter questionnaire item was 
based on its consistent ability to identify the workplace 
exposures of interest (Blanc and Torén 2007). In addi-
tion to self-reported VGDF, work-related exposure likeli-
hood was assessed using a COPD-specific JEM based on 
longest held job. This categorised each subject into jobs 
that were either of low or moderate-to-high likelihood of 
exposure to inhalants associated with COPD risk (Blanc 
et al. 2005).
Those agreeing to participate in this phase of the study 
underwent lung function assessment and completed an 
additional questionnaire during a home visit. The forced 
expiratory volume in one second (FEV1) and forced vital 
capacity (FVC) were measured and for each participant, 
according to the most recent American Thoracic Society 
and European Respiratory Society guidelines (American 
Thoracic Society/European Respiratory Society 2005). 
This was done using a standard, verified, rotameter-based 
portable spirometer (Microlab, MicroMedical, Roches-
ter, UK). As the lung function testing was carried out at 
home, bronchodilators were not given prior to lung func-
tion testing.
During these home visits, each participant also self-
completed the EQ5D. This was comprised of five items 
assessing different health-related domains (mobility, self-
care, usual activities, pain/discomfort and anxiety/depres-
sion), each having three levels of response (no problems, 
some/moderate problems and extreme problems/inability 
to perform tasks). The scores from these domains can be 
used to generate a single summary utility index (in the UK 
validated against the VAS) by applying scores from the 
EQ5D preference weights measured in general population 
samples. In addition, a separate EQ5D vertical VAS was 
administered to record the current health state of the par-
ticipant; ranging from the “worst imaginable health state” 
to the “best imaginable health state”.
To assess socio-economic deprivation (SED) for each 
study participant, the percentage of households within the 
same postcode (generally containing 10–12 residences) 
receiving Income Support (%IS), a form of UK-based 
financial benefit, was used. Previous UK-based work sup-
ports such an approach (Danesh et al. 1999).
Data were analysed using SPSS (Version 14). Univariate 
analysis estimated the associations among the variables of 
potential study interest and EQ5D scores for each domain, 
the overall score and the VAS. Based on these findings, 
multivariate linear regression models were constructed 
taking into account both COPD and work-related VGDF 
exposure (self-reported and JEM assigned) as independent 
predictors of EQ5D, including other key covariates as well. 
Additional analyses were also performed stratified by the 
presence or absence of COPD.
In the entire study group, the independent predictor 
variables of a priori study interest were as follows: age, 
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sex, %IS, pack-years of smoking (calculated from aver-
age daily number of cigarettes smoked and duration of 
smoking), ever previously exposed to VGDF at work 
(using both self-reported and JEM assignment), FEV1 as 
a percentage of the predicted value (Quanjer et al. 1983) 
(%FEV1) and a self-reported physician diagnosis of 
COPD. Although in the analysis stratified by presence or 
absence of COPD that variable was excluded as an inde-
pendent covariate, the percentage predicted FEV1 was 
retained in the models.
Estimates of the effect of each independent variable 
was estimated using the unstandardised β coefficient only 
and its associated 95 % confidence limit (95 % CI). These 
were not converted to standardised coefficients, in order 
to allow direct understanding of the effect of the predic-
tor variable in its own units. The overall fit of the model 
was assessed by the R2 metric. The associations of %IS, 
age, pack-years of smoking, and FEV1 % predicted were 
quantified per 10 units (i.e. per 10 years of age, etc.). The 
final regression output was assessed for normality by 
developing a frequency plot of the standardised regres-
sion residuals, ensuring that this approximated to a normal 
distribution.
This study received approval from both the NHS 
Research Ethics Committee of the UK (IRAS; Integrated 
Research Application System) and the Sheffield Teaching 
Hospitals NHS Foundation Trust Research and Develop-
ment Office.
Results
Of 2001 initial questionnaire respondents, 623 individu-
als completed the EQ5D and underwent lung function 
assessment in home visits (Table 1). Of these, 148 (24 %) 
reported having received a physician’s diagnosis of COPD, 
105 from the general population sample and 43 from the 
lung physiology laboratory-based recruitment.
The majority of the participants (355; 57 %) was male, 
and 386 (62 %) were ever smokers. The mean age of the 
participants was 67.1 years, and the mean level of %IS for 
the group was 14.3 %. Of the entire study population, a 
minority of the 149 (24 %) were currently working at the 
time of study. The majority (368; 59 %) reported ever hav-
ing been regularly exposed to VGDF in their longest held 
job, while 326 (52.3 %) were classified based on the JEM 
as having been in a longest held job with likely exposure.
Table 1 shows further data on demographics, lung func-
tion, disability and HRQoL, stratified by the presence or 
absence of a reported physician’s diagnosis of COPD. The 
148 individuals with COPD were older, had higher levels of 
socioeconomic deprivation, were more likely to be past or 
current smokers, were less likely to be currently employed 
and, consistent with their reported physician’s diagnosis, 
on average had 720 mls lower FEV1 (all p < 0.01). Adverse 
occupational factors, whether by self-report of VGDF or 
by JEM, were more prevalent in the COPD stratum. The 
EQ5D VAS score was significantly lower in the group with 
Table 1  Characteristics among 623 study participants stratified by COPD status
For participants with missing responses, study (n) presented
SD standard deviation, VGDF vapours, gases, dust or fume exposure, JEM job exposure matrix, FEV1 forced expiratory volume in 1 s, EQ5D 
VAS EuroQol five dimension visual analogue scale quality-of-life measure
Utility index; summary score derived from a combination of the 5 EQ5D domains, used as a single measure of HRQoL with a maximum value 
of 1.0 (1.0 representing the best QOL)
This is done by applying scores from the EQ5D preference weights measured in general population samples
* p value compares Chronic Obstructive Pulmonary Disease (COPD) and non-COPD groups
a Chi-squared tests (or Fisher’s exact equivalent)
b Independent samples t test
Subject demographics, work exposures and quality-
of-life responses
All (n = 623) COPD (n = 148) Non-COPD (n = 475) p*
Male [n (%)] 355 (57) 92 (62.2) 263 (55.4) 0.16a
Age in years [mean (SD)] 67.1 (8.0) 69.4 (8.2) 66.4 (7.7) <0.05b
% Numbers of individuals receiving income support 
in postcode area [mean (SD)]
18.6 (16.4) 22.8 (14.9) (n = 103) 17.6 (16.6) (n = 427) <0.05a
Ever smoker [n (%)] 386 (62.1) 126 (85.1) (n = 147) 260 (54.7) (n = 474) <0.05a
Ever VGDF exposed [n (%)] 368 (59.3) 117 (79.1) (n = 143) 251 (52.8) (n = 464) <0.05a
JEM exposure 2 or 3 [n (%)] 326 (52.3 %) 95 (64 %) 231 (48.6 %) <0.05a
Mean FEV1 in litres [Mean (SD)] 2.20 (0.77) 1.65 (0.7) 2.37 (0.7) <0.05
b
Equation 5D VAS [Mean (SD)] 70.8 (19.1) 57.0 (16.5) (n = 146) 75 (17.8) (n = 472) <0.05b
Utility index [Mean (SD)] 0.68 (0.31) 0.52 (0.32) 0.73 (0.30) <0.05b
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COPD. There was also a parallel decrement in the numeric 
EQ5D composite utility index comparing those with and 
without self-reported COPD.
The presence of self-reported COPD also was associ-
ated with a poorer HRQoL as assessed by each of the five 
EQ5D domains (data not in Table). For example, of those 
with self-reported COPD, 80 % reported any problem with 
mobility (combining the two higher categories and exclud-
ing no problem), 34 % for self-care, 74 % for usual activi-
ties, 78 % for pain and discomfort and 46 % for anxiety/
depression. The respective figures for those without self-
reported COPD were as follows: mobility 44 %, self-care 
11 %, usual activities 36 %, pain and discomfort 58 %, and 
anxiety/depression 26 %.
Table 2 details the EQ5D domain and total scores strati-
fied in two ways: by self-reported VGDF exposure and 
exposures assessed by JEM. As shown, HRQoL was sig-
nificantly lower in the presence of both self-reported VGDF 
exposure and JEM-based exposure. Particularly high levels 
of reported pain and discomfort were seen within both the 
JEM highly exposed and VGDF-exposed strata. Overall 
mean utility index and VAS scores indicated exposure-
associated poorer HRQoL.
Table 3 shows the results of the multiple linear regres-
sion analysis carried out for 564 of the study population 
(137 with COPD, 427 without COPD), representing all 
those with complete data for all key variables. Older age, 
female sex, greater levels of socioeconomic deprivation, 
Table 2  EQ5D domain scores 
stratified by JEM and VGDF 
exposures
Higher EQ5D dimension levels 
2–3 indicate poorer quality of 
life than level 1
VGDF vapours, gases, dust 
or fume exposure, JEM job 
exposure matrix
* p values derived by Chi-
squared testing
** p values from independent 
samples t test
Equation 5D dimension JEM p value VGDF p value
Not exposed Exposed VGDF No VGDF
Mobility Level 1 161 134 147 141
Level 2–3 136 192 <0.05* 221 98 <0.05*
Self-care Level 1 254 261 291 212
Level 2–3 41 64 0.06* 74 27 <0.05*
Usual activities Level 1 179 161 172 158
Level 2–3 118 165 <0.05* 196 81 <0.05*
Pain discomfort Level 1 128 105 <0.05* 114 114
Level 2–3 169 221 254 125 <0.05*
Anxiety/depression Level 1 208 218 0.42* 237 179
Level 2–3 87 105 126 60 <0.05*
Mean VAS score 72.8 68.9 <0.05** 67.7 75.0 <0.05**
Mean utility index 0.72 0.65 <0.05** 0.64 0.75 <0.05**
Table 3  Multivariate analysis of predictors of health-related quality of life (EQ5D) among 564 study participants
Dependent variable is the EQ5D utility index
Adjusted models are mutually adjusted for all variables in the model
All associations p < 0.05 except female in unadjusted model (p = 0.056) and pack-years in the adjusted model (p = 0.06)
Utility index; summary score derived from a combination of the 5 EQ5D domains, used as a single measure of HRQoL with a maximum value 
of 1 (1 representing the best HRQoL). This is done by applying scores from the EQ5D preference weights measured in general population sam-
ples
JEM job exposures matrix-based exposure (see Methods)
Explanatory variables Univariate analysis unstandardised regression 
coefficient
Multivariate analysis unstandardised 
regression coefficient
β 95 % CI β 95 % CI
Percentage income support (per 10 % increment) −0.06 −0.07 −0.04 −0.03 −0.05 −0.02
Age (years, per 10 years) −0.08 −0.11 −0.05 −0.05 −0.08 −0.02
Female −0.049 −0.099 0.001 −0.121 −0.174 −0.068
Pack-years (per 10 pack-years) −0.03 −0.04 −0.02 −0.01 −0.02 0.0005
JEM exposure −0.076 −0.126 −0.027 −0.069 −0.123 −0.016
FEV1 % predicted (per 10 %) 0.04 0.03 0.05 0.02 0.01 0.03
Self-reported COPD −0.207 −0.263 −0.151 −0.090 −0.155 −0.026
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lower percentage predicted FEV1 and a reported diagno-
sis of COPD were significantly associated with poorer 
HRQoL. Taking all of these covariates into account in the 
multivariate model, a higher likelihood of occupational 
exposure by JEM remained associated with poorer HRQoL 
(β estimate: −0.069; p < 0.05).
A further analysis including the variable “currently 
working” found a positive association with HRQoL of 
being currently employed, while estimates for the remain-
ing covariates remained similar to the previous model (data 
not shown). Additional analysis of the association between 
occupational exposure defined by JEM but using EQ5D 
measured with the VAS instrument as the dependent varia-
ble, including the same covariates, yielded a negative direc-
tion of effect consistent with that seen with using point 
scale EQ5D measure, but the relationship was not statisti-
cally significant (β = −2.9; p = 0.074) (data not shown in 
Table).
Table 4 shows the results of a subsequent regression 
analysis stratified by the presence or absence of self-
reported COPD. Within the self-reported COPD group, the 
negative effect of JEM exposure manifested wider confi-
dence intervals including zero and hence nonsignificant, 
but the point estimate of the negative effect (β = −0.070) 
was similar to the entire group and to the non-COPD stra-
tum, in which the association remained statistically sig-
nificant. The estimates for the relationship between pack-
years of smoking and HRQoL were also similar across the 
strata. Of note, the magnitude the SES effect appeared to be 
greater among those in the COPD stratum.
In an alternate model (identical to Table 3 but using self-
reported VGDF in place of JEM), in the entire group expo-
sure by this measure did have a negative association with 
HRQoL (β = −0.109, p < 0.05). Similarly, when strati-
fied by COPD status (identical to Table 4 but using VGDF 
rather than JEM), exposure by this measure again had a 
negative association with HRQoL (β = −0.199, p < 0.05) 
for those with COPD and also for those without COPD 
(β = −0.081, p < 0.05).
All standardised regression residual plots, for the regres-
sion data shown, approximated to a normal distribution.
Discussion
Although this population-based study was designed to 
estimate the contribution of occupational exposures to the 
presence of self-reported COPD as its primary endpoint, it 
provided the opportunity to analyse occupational factors in 
relation to HRQoL as a secondary outcome measure. We 
found that attributes of subjects’ longest held job, specifi-
cally the likelihood of inhalant exposure based on a JEM 
assignment and self-report of exposure to VGDF, were 
associated with poorer HRQoL, This was true even tak-
ing into account demographics, a self-reported physician’s 
diagnosis of COPD, and lung function. Moreover, occupa-
tional exposure defined by JEM was associated with poorer 
HRQoL even among those without COPD, with similar 
estimates of effect to that of the COPD stratum. Although 
the latter point estimate was similar, the 95 % CI included 
Table 4  Multiple regression analysis of independent predictors of health-related quality of life using the EQ5D utility index stratified by COPD 
status
For the EQ5D utility index, summary scores are derived from a combination of the 5 EQ5D domains, used as a single measure of HRQoL with a 
maximum value of 1 (1 representing the best QOL) (see Methods)
JEM job exposure matrix
Explanatory variables Unstandardised β coefficient p value 95 % confidence interval 
for β
Lower limit Upper limit
COPD (n = 137)
Percentage income support per postcode (per 10 % change) −0.02 0.35 −0.05 0.02
Age (per 10 years) 0.002 0.61 −0.05 0.08
Female −0.167 <0.05 −0.283 −0.050
Pack-years (per 10 pack year units) −0.02 0.07 −0.03 0.000
JEM Exposure −0.070 0.26 −0.192 0.051
No COPD (n = 427)
Percentage income support per postcode (per 10 % change) −0.04 <0.05 −0.06 −0.03
Age (per 10 years) −0.07 <0.05 −0.11 −0.04
Female −0.096 <0.05 −0.155 −0.037
Pack-years (per 10 pack year units) −0.02 <0.05 −0.03 −0.0003
JEM exposure −0.061 <0.05 −0.121 −0.020
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zero. Because the measure of HRQoL we used was not res-
piratory specific, this suggests that poorer working condi-
tions may impact HRQoL in ways not limited to adverse 
effects on the lung. Notably, the association with self-
reported VGDF, unlike the JEM-based exposure measure, 
was stronger in the COPD stratum (b = −0.199, p < 0.05), 
consistent with a reporting bias (those with disease and 
poorer HRQoL may have been more likely to report VGDF 
exposure). In terms of the analysis confined to the COPD 
stratum, only the effect of gender persisted significantly 
following adjusted analyses. The potential predictor vari-
ables included in the analysis we believe are valid. These 
variables had predicted HRQoL in the study group as a 
whole, and it was for this reason that they were retained in 
the analysis of the COPD only stratum.
The possible relationship between adverse outcomes in 
COPD being related to previous workplace-based expo-
sures has been raised to our knowledge very uncommonly 
in the literature. A single previous study identified a rela-
tionship between having both reported VGDF exposures 
and respiratory-related work disability as predicting the 
greatest risk at 12 months follow-up for restricted activity 
days attributed to a breathing or lung problem, although 
this study did not report HRQoL (Blanc et al. 2004).
The limitations of this analysis should temper the interpre-
tation of our findings. This was a cross-sectional analysis pre-
cluding causal inference. Further, these data are taken from 
a study whose primary intent was to assess the association 
between COPD and occupational exposure. The association 
between self-reported VGDF and poorer HRQoL, as noted 
above, is likely to be impacted by reporting bias. This would 
not explain, however, the association we observed between 
HRQoL and JEM-based exposure, which was not affected 
by recall of exposure. Moreover, JEM-based exposure mani-
fested a similar relation to HRQoL among those with and 
without COPD, although the effect within the COPD stra-
tum was not statistically significant. Because the EQ5D is a 
generic rather than respiratory specific HRQoL measure, we 
cannot argue that its relationship to exposures on the long-
est held job reflects adverse respiratory effects per se and, 
furthermore, the association was present even taking COPD 
diagnosis and lung function into account in multivariate mod-
elling. Were jobs with poorer working conditions simply a 
surrogate for lower SES, we would have expected adjustment 
for neighbourhood deprivation to have substantially weak-
ened the association we observed, which was not the case. 
Of interest, there was indeed a lower SES-associated negative 
association with HRQoL, although this appeared to be driven 
by an association within the COPD stratum.
Selection effects of those with ill health could have influ-
enced our findings and may limit their generalisability. Argu-
ing against this, the mean EQ5D VAS score of 80 (Inter-
quartile range; IQR 29.5) within the stratum of our study 
population without self-reported COPD is similar to reported 
population norms of 83.7, 78.2 and 72.9 (males), and 80.3, 
76.6 and 74.2 (females) for age groups 55–65, 64–75, and 
75+, respectively (Szende et al. 2014). We also observed 
similarly consistent findings with the question-based EQ5D 
instrument. Our study size is relatively modest and accounts 
for the wide confidence intervals observed, especially within 
the COPD stratum. We also acknowledge that the definition 
of COPD we applied (self-reported physician diagnosed 
COPD, including COPD, emphysema or chronic bronchitis) 
may have led to misclassification error. By including in our 
multivariate analysis FEV1 per cent predicted, we accounted 
for this in part, as well as capturing disease severity within 
the COPD group. Although this may have led to a degree of 
“over-adjustment” insofar as COPD is concerned, it should 
not explain the association with HRQoL that we did observe 
for occupational inhalant exposure on the longest held job. 
Finally, we cannot exclude unaccounted for confounding 
between job exposures and some other factor or factors driv-
ing poorer HRQoL. For example, those exposed by JEM or 
VGDF may have been in certain job types that increased the 
risk of mental ill health or selected for such problems.
Despite these potential limitations, our findings sug-
gest that work may have an important link to HRQoL and 
that this can persist even among those who have retired. In 
COPD, HRQoL is even worse than among those without 
this condition, but the work-associated decrement appears 
to be similar across the COPD and non-COPD strata, at 
least in terms of the generic measure we used. It will be 
important to further elucidate these relations, including 
with disease-specific HRQoL measures, in longitudinal 
studies. This will require, however, considerable accumu-
lated follow-up, well past the span of active labour force 
participation, in order to fully assess the potential impact of 
work on the key patient-centred outcome of quality of life.
Acknowledgments The authors would like to thank all the partici-
pants in this study, and both Catherine Billings and Clare Billings for 
their assistance.
Conflict of interest The authors declare that they have no conflicts 
of interest. The content of this publication reflects the views of the 
authors, and not necessarily that of HSE.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribu-
tion, and reproduction in any medium, provided the original author(s) 
and the source are credited.
References
Almagro P, Castro A (2013) Helping COPD patients change health 
behavior in order to improve their quality of life. Int J Chron 
Obstruct Pulmon Dis 8:335–345
805Int Arch Occup Environ Health (2015) 88:799–805 
1 3
American Thoracic Society Statement (2003) Occupational contribu-
tion to the burden of airway disease. Am J Respir Crit Care Med 
67:787–797
American Thoracic Society/European Respiratory Society (2005) 
General considerations for lung function testing. Eur Respir J 
26:153–161
Blanc P, Torén K (2007) Occupation in chronic obstructive lung dis-
ease and chronic bronchitis: an update. Int J Tuberc Lung Dis 
11(3):251–257
Blanc PD, Eisner MD, Trupin L, Yelin EH, Katz PP, Balmes JR 
(2004) The association between occupational factors and adverse 
health outcomes in chronic obstructive pulmonary disease. Occup 
Environ Med 61:661–667
Blanc PD, Eisner MD, Balmes JR, Trupin L, Yelin EH (2005) Katz 
PP. Exposure to vapors, gas, dust, or fumes: assessment by a sin-
gle survey item compared to a detailed exposure battery and a job 
exposure matrix. Am J Ind Med 48(2):110–117
Brooks R, Rabin R, De Charro F (eds) (2003) The measurement and 
valuation of health status using EQ-5D: a European perspective; 
evidence from the EuroQol BIOMED research programme, 1st 
edn. Kluwer Academic Publishers, Dordrecht, The Netherlands
Danesh J, Gault S, Semmence J, Appleby P, Peto R (1999) Postcodes 
as useful markers of income in 26,000 British households. J Epi-
demiol Commun Health 53(9):582
Darby A, Waterhouse J, Stevens V et al (2012) Chronic obstructive 
pulmonary disease among residents of a historically industrial-
ised area. Thorax 67(10):901–907
Jones PW, Agusti AG (2006) Outcomes and markers in the assess-
ment of chronic obstructive pulmonary disease. Eur Respir J 
27(4):822–832
Mahler DA (2000) How should health-related quality of life be 
assessed in patients with COPD? Chest 117(2 Suppl):54S–57S
Menn P, Weber N, Holle R (2010) Health-related quality of life in 
patients with severe COPD hospitalized for exacerbations—com-
paring EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes 
15(8):39
Quanjer P, Dalhuijsen A, Van Zoramen B (1983) Standardised lung 
function testing. Report of the working party for the European 
community for coal and steel. Bull Eur Physiopathol Respir 
19(suppl. 5):1–95
Szende A, Janssen B, Cabases J (eds) (2014) Self-Reported Popula-
tion Health: An International Perspective based on EQ-5D. XV, 
196 p. ISBN 978-94-007-7595-4
The EuroQol Group (2013) http://www.euroqol.org/fileadmin/
user_upload/Documenten/PDF/Folders_Flyers/EQ-5D-3L_User-
Guide_2013_v5.0_October_2013.pdf. Accessed 11 Dec 2014
